Relmada Therapeutics, Inc Email Format

Pharmaceutical ManufacturingFlorida, United States11-50 Employees

Relmada Therapeutics is a clinical-stage biotechnology company committed to advancing innovative breakthrough therapies that have the potential to bring meaningful clinical benefits to targeted patient populations.

Lead investigational program, NDV-01, for High-Grade Non-Muscle Invasive Bladder Cancer, is being evaluated in a Phase 2 study. In addition, preparations are underway to advance sepranolone, a Phase 2b-ready investigational program for compulsion-related disorders including Tourette’s Syndrome and Prader-Willi syndrome, into further studies.

For more information, visit www.relmada.com.

Sign up for free to view info

Company overview Employee directory